137 related articles for article (PubMed ID: 632750)
1. Lysis of oncornaviruses by human serum. Isolation of the viral complement (C1) receptor and identification as p15E.
Bartholomew RM; Esser AF; Müller-Eberhard HJ
J Exp Med; 1978 Mar; 147(3):844-53. PubMed ID: 632750
[TBL] [Abstract][Full Text] [Related]
2. Lysis of RNA tumor viruses by human serum: direct antibody-independent triggering of the classical complement pathway.
Cooper NR; Jensen FC; Welsh RM; Oldstone MB
J Exp Med; 1976 Oct; 144(4):970-84. PubMed ID: 62019
[TBL] [Abstract][Full Text] [Related]
3. Differences in activation of human and guinea pig complement by retroviruses.
Bartholomew RM; Esser AF
J Immunol; 1978 Nov; 121(5):1748-51. PubMed ID: 213489
[TBL] [Abstract][Full Text] [Related]
4. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
Fearon DT; Austen KF; Ruddy S
Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
[No Abstract] [Full Text] [Related]
5. Quantitation of the membrane attack complex of complement in an air-driven ultracentrifuge.
Bartholomew RM; Podack ER; Esser AF
J Immunol Methods; 1979; 31(3-4):351-60. PubMed ID: 521635
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41.
Ebenbichler CF; Thielens NM; Vornhagen R; Marschang P; Arlaud GJ; Dierich MP
J Exp Med; 1991 Dec; 174(6):1417-24. PubMed ID: 1744579
[TBL] [Abstract][Full Text] [Related]
7. [Complement activation and biological activities].
Inoue K
Nihon Saikingaku Zasshi; 1976 Jul; 31(4):535-55. PubMed ID: 988219
[No Abstract] [Full Text] [Related]
8. Association of moloney murine leukaemia virus proteins: an assay for hydrophobic protein-protein interactions.
Andersen KB
J Gen Virol; 1982 Jan; 58 Pt 1():83-93. PubMed ID: 7142970
[TBL] [Abstract][Full Text] [Related]
9. Moloney leukemia virus-induced cell surface antigen: detection and characterization in sodium dodecyl sulfate gels.
Troy FA; Fenyö EM; Klein G
Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5270-4. PubMed ID: 74831
[TBL] [Abstract][Full Text] [Related]
10. On the mechanism of cell membrane damage by complement: evidence on insertion of polypeptide chains from C8 and C9 into the lipid bilayer of erythrocytes.
Hammer CH; Shin ML; Abramovitz AS; Mayer MM
J Immunol; 1977 Jul; 119(1):1-8. PubMed ID: 559700
[TBL] [Abstract][Full Text] [Related]
11. C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions.
Biesecker G; Podack ER; Halverson CA; Müller-Eberhard HJ
J Exp Med; 1979 Feb; 149(2):448-58. PubMed ID: 762498
[TBL] [Abstract][Full Text] [Related]
12. Deviated lysis: transfer of complement lytic activity to unsensitized cells. IV. Parital isolation of the activity.
Hänsch G; Rother U; Rother K
Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):48-59. PubMed ID: 868206
[TBL] [Abstract][Full Text] [Related]
13. Protection of retroviral vector particles in human blood through complement inhibition.
Rother RP; Squinto SP; Mason JM; Rollins SA
Hum Gene Ther; 1995 Apr; 6(4):429-35. PubMed ID: 7612700
[TBL] [Abstract][Full Text] [Related]
14. C1 fixation and classical complement pathway activation by a fragment of the Cmu4 domain of IgM.
Hurst MM; Volanakis JE; Stroud RM; Bennett JC
J Exp Med; 1975 Nov; 142(5):1322-6. PubMed ID: 1194853
[TBL] [Abstract][Full Text] [Related]
15. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
Rollins SA; Sims PJ
J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760
[TBL] [Abstract][Full Text] [Related]
16. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide.
Green N; Shinnick TM; Witte O; Ponticelli A; Sutcliffe JG; Lerner RA
Proc Natl Acad Sci U S A; 1981 Oct; 78(10):6023-7. PubMed ID: 6947213
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
[TBL] [Abstract][Full Text] [Related]
18. Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.
Joiner KA; Hammer CH; Brown EJ; Cole RJ; Frank MM
J Exp Med; 1982 Mar; 155(3):797-808. PubMed ID: 6801179
[TBL] [Abstract][Full Text] [Related]
19. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
Brown EJ; Ramsey J; Hammer CH; Frank MM
J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
[TBL] [Abstract][Full Text] [Related]
20. The reactivity of the complement system.
Hadding U
Monogr Allergy; 1977; 12():36-45. PubMed ID: 335218
[No Abstract] [Full Text] [Related]
[Next] [New Search]
